Cargando…
Characterization of the GBoV1 Capsid and Its Antibody Interactions
Human bocavirus 1 (HBoV1) has gained attention as a gene delivery vector with its ability to infect polarized human airway epithelia and 5.5 kb genome packaging capacity. Gorilla bocavirus 1 (GBoV1) VP3 shares 86% amino acid sequence identity with HBoV1 but has better transduction efficiency in seve...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924616/ https://www.ncbi.nlm.nih.gov/pubmed/33672786 http://dx.doi.org/10.3390/v13020330 |
_version_ | 1783659126357753856 |
---|---|
author | Yu, Jennifer Chun Mietzsch, Mario Singh, Amriti Jimenez Ybargollin, Alberto Kailasan, Shweta Chipman, Paul Bhattacharya, Nilakshee Fakhiri, Julia Grimm, Dirk Kapoor, Amit Kučinskaitė-Kodzė, Indrė Žvirblienė, Aurelija Söderlund-Venermo, Maria McKenna, Robert Agbandje-McKenna, Mavis |
author_facet | Yu, Jennifer Chun Mietzsch, Mario Singh, Amriti Jimenez Ybargollin, Alberto Kailasan, Shweta Chipman, Paul Bhattacharya, Nilakshee Fakhiri, Julia Grimm, Dirk Kapoor, Amit Kučinskaitė-Kodzė, Indrė Žvirblienė, Aurelija Söderlund-Venermo, Maria McKenna, Robert Agbandje-McKenna, Mavis |
author_sort | Yu, Jennifer Chun |
collection | PubMed |
description | Human bocavirus 1 (HBoV1) has gained attention as a gene delivery vector with its ability to infect polarized human airway epithelia and 5.5 kb genome packaging capacity. Gorilla bocavirus 1 (GBoV1) VP3 shares 86% amino acid sequence identity with HBoV1 but has better transduction efficiency in several human cell types. Here, we report the capsid structure of GBoV1 determined to 2.76 Å resolution using cryo-electron microscopy (cryo-EM) and its interaction with mouse monoclonal antibodies (mAbs) and human sera. GBoV1 shares capsid surface morphologies with other parvoviruses, with a channel at the 5-fold symmetry axis, protrusions surrounding the 3-fold axis and a depression at the 2-fold axis. A 2/5-fold wall separates the 2-fold and 5-fold axes. Compared to HBoV1, differences are localized to the 3-fold protrusions. Consistently, native dot immunoblots and cryo-EM showed cross-reactivity and binding, respectively, by a 5-fold targeted HBoV1 mAb, 15C6. Surprisingly, recognition was observed for one out of three 3-fold targeted mAbs, 12C1, indicating some structural similarity at this region. In addition, GBoV1, tested against 40 human sera, showed the similar rates of seropositivity as HBoV1. Immunogenic reactivity against parvoviral vectors is a significant barrier to efficient gene delivery. This study is a step towards optimizing bocaparvovirus vectors with antibody escape properties. |
format | Online Article Text |
id | pubmed-7924616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79246162021-03-03 Characterization of the GBoV1 Capsid and Its Antibody Interactions Yu, Jennifer Chun Mietzsch, Mario Singh, Amriti Jimenez Ybargollin, Alberto Kailasan, Shweta Chipman, Paul Bhattacharya, Nilakshee Fakhiri, Julia Grimm, Dirk Kapoor, Amit Kučinskaitė-Kodzė, Indrė Žvirblienė, Aurelija Söderlund-Venermo, Maria McKenna, Robert Agbandje-McKenna, Mavis Viruses Article Human bocavirus 1 (HBoV1) has gained attention as a gene delivery vector with its ability to infect polarized human airway epithelia and 5.5 kb genome packaging capacity. Gorilla bocavirus 1 (GBoV1) VP3 shares 86% amino acid sequence identity with HBoV1 but has better transduction efficiency in several human cell types. Here, we report the capsid structure of GBoV1 determined to 2.76 Å resolution using cryo-electron microscopy (cryo-EM) and its interaction with mouse monoclonal antibodies (mAbs) and human sera. GBoV1 shares capsid surface morphologies with other parvoviruses, with a channel at the 5-fold symmetry axis, protrusions surrounding the 3-fold axis and a depression at the 2-fold axis. A 2/5-fold wall separates the 2-fold and 5-fold axes. Compared to HBoV1, differences are localized to the 3-fold protrusions. Consistently, native dot immunoblots and cryo-EM showed cross-reactivity and binding, respectively, by a 5-fold targeted HBoV1 mAb, 15C6. Surprisingly, recognition was observed for one out of three 3-fold targeted mAbs, 12C1, indicating some structural similarity at this region. In addition, GBoV1, tested against 40 human sera, showed the similar rates of seropositivity as HBoV1. Immunogenic reactivity against parvoviral vectors is a significant barrier to efficient gene delivery. This study is a step towards optimizing bocaparvovirus vectors with antibody escape properties. MDPI 2021-02-20 /pmc/articles/PMC7924616/ /pubmed/33672786 http://dx.doi.org/10.3390/v13020330 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yu, Jennifer Chun Mietzsch, Mario Singh, Amriti Jimenez Ybargollin, Alberto Kailasan, Shweta Chipman, Paul Bhattacharya, Nilakshee Fakhiri, Julia Grimm, Dirk Kapoor, Amit Kučinskaitė-Kodzė, Indrė Žvirblienė, Aurelija Söderlund-Venermo, Maria McKenna, Robert Agbandje-McKenna, Mavis Characterization of the GBoV1 Capsid and Its Antibody Interactions |
title | Characterization of the GBoV1 Capsid and Its Antibody Interactions |
title_full | Characterization of the GBoV1 Capsid and Its Antibody Interactions |
title_fullStr | Characterization of the GBoV1 Capsid and Its Antibody Interactions |
title_full_unstemmed | Characterization of the GBoV1 Capsid and Its Antibody Interactions |
title_short | Characterization of the GBoV1 Capsid and Its Antibody Interactions |
title_sort | characterization of the gbov1 capsid and its antibody interactions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924616/ https://www.ncbi.nlm.nih.gov/pubmed/33672786 http://dx.doi.org/10.3390/v13020330 |
work_keys_str_mv | AT yujenniferchun characterizationofthegbov1capsidanditsantibodyinteractions AT mietzschmario characterizationofthegbov1capsidanditsantibodyinteractions AT singhamriti characterizationofthegbov1capsidanditsantibodyinteractions AT jimenezybargollinalberto characterizationofthegbov1capsidanditsantibodyinteractions AT kailasanshweta characterizationofthegbov1capsidanditsantibodyinteractions AT chipmanpaul characterizationofthegbov1capsidanditsantibodyinteractions AT bhattacharyanilakshee characterizationofthegbov1capsidanditsantibodyinteractions AT fakhirijulia characterizationofthegbov1capsidanditsantibodyinteractions AT grimmdirk characterizationofthegbov1capsidanditsantibodyinteractions AT kapooramit characterizationofthegbov1capsidanditsantibodyinteractions AT kucinskaitekodzeindre characterizationofthegbov1capsidanditsantibodyinteractions AT zvirblieneaurelija characterizationofthegbov1capsidanditsantibodyinteractions AT soderlundvenermomaria characterizationofthegbov1capsidanditsantibodyinteractions AT mckennarobert characterizationofthegbov1capsidanditsantibodyinteractions AT agbandjemckennamavis characterizationofthegbov1capsidanditsantibodyinteractions |